Published in J Headache Pain on February 08, 2013
Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry (2014) 0.89
Medication-overuse headache: a review. J Pain Res (2014) 0.85
Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf (2014) 0.79
Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol (2016) 0.78
Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial. J Neurol (2015) 0.76
Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain (2016) 0.76
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study. J Headache Pain (2017) 0.75
[Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders]. Schmerz (2014) 0.75
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol (2011) 2.53
Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology (2004) 2.41
Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology (2006) 2.28
Medication-overuse headache: a worldwide problem. Lancet Neurol (2004) 2.11
Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia (2008) 2.09
Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology (2009) 1.73
Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia (2005) 1.72
Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med (2010) 1.49
Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol (2010) 1.44
Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain (2011) 1.39
Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol (2011) 1.31
Treatment of medication overuse headache--guideline of the EFNS headache panel. Eur J Neurol (2011) 1.30
Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia (2011) 1.19
Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol (2011) 1.18
Medication overuse headache: biobehavioral issues and solutions. Headache (2006) 1.13
Prevalence of chronic migraine and medication overuse headache in Germany--the German DMKG headache study. Cephalalgia (2010) 1.06
Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia (2008) 1.03
A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain (2009) 1.03
Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia (2006) 1.00
What is the role of dependence-related behavior in medication-overuse headache? Headache (2010) 0.94
Medication-overuse headache: where are we now? Curr Opin Neurol (2007) 0.92
What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? J Headache Pain (2011) 0.91
Detoxification for medication overuse headache is the primary task. Cephalalgia (2011) 0.88
Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache. Pain (2012) 0.87
Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia (2012) 0.86
How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia (2008) 0.85
Practical management of medication-overuse headache. Acta Neurol Belg (2006) 0.85
In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial. Cephalalgia (2011) 0.84
Management of medication-overuse headache. Expert Rev Neurother (2007) 0.84
Detoxification for medication overuse headache is not necessary. Cephalalgia (2011) 0.81
Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia (2012) 2.48
Spontaneous intracranial hypotension syndrome: report of twelve cases. Headache (2004) 2.26
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain (2011) 1.75
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet (2006) 1.56
Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache (2009) 1.54
Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia (2010) 1.40
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 1.20
The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain (2014) 1.17
Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain (2013) 1.16
REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord (2008) 1.15
Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain (2014) 1.14
Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil (2003) 1.11
Italian guidelines for primary headaches: 2012 revised version. J Headache Pain (2012) 1.10
Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain (2004) 1.08
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant (2009) 1.05
A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain (2009) 1.03
REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord (2006) 1.03
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics (2002) 1.02
Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res (2009) 1.02
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci (2007) 0.99
Nitroglycerin induces hyperalgesia in rats--a time-course study. Eur J Pharmacol (2003) 0.99
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord (2003) 0.97
Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache (2006) 0.97
From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain (2009) 0.97
Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord (2006) 0.97
The Headache Under-Response to Treatment (HURT) Questionnaire: assessment of utility in headache specialist care. Cephalalgia (2012) 0.97
Sexual function and distress in women treated for primary headaches in a tertiary university center. J Sex Med (2012) 0.96
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf (2002) 0.96
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain (2011) 0.95
Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett (2002) 0.95
Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord (2009) 0.94
Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study. Eur J Pain (2010) 0.93
Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat. Neurosci Lett (2004) 0.91
Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts. Cephalalgia (2010) 0.91
Childhood and adolescent migraine: a neuropsychiatric disorder? Med Hypotheses (2011) 0.91
Identification of novel pharmacological targets to minimize excitotoxic retinal damage. Int Rev Neurobiol (2009) 0.90
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol Dis (2005) 0.90
Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta (2005) 0.90
Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain (2010) 0.89
An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain (2012) 0.89
Identification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat. Brain Res (2009) 0.89
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol. FEBS J (2007) 0.89
The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility. Neurosci Lett (2009) 0.88
Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology (2005) 0.87
Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization. Mov Disord (2011) 0.87
Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spa therapies. Clin Biochem (2010) 0.87
Headache yesterday in Europe. J Headache Pain (2014) 0.87
Four-week trunk-specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease. Mov Disord (2010) 0.87
Reduced-intensity modified constraint-induced movement therapy versus conventional therapy for upper extremity rehabilitation after stroke: a multicenter trial. Neurorehabil Neural Repair (2012) 0.87
Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache (2012) 0.87
Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment. Funct Neurol (2007) 0.87
Use of complementary and alternative medicine by patients with cluster headache: results of a multi-centre headache clinic survey. Complement Ther Med (2007) 0.87
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model. J Headache Pain (2014) 0.86
A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. Int Rev Neurobiol (2007) 0.86
Effects of anandamide in migraine: data from an animal model. J Headache Pain (2011) 0.86
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens (2011) 0.85
Reproductive life milestones in women with Parkinson's disease. Funct Neurol (2004) 0.85
Prevention of Glutamate Accumulation and Upregulation of Phospho-Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat. Int Rev Neurobiol (2009) 0.85
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. Neurobiol Dis (2007) 0.85
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med (2004) 0.85
Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs (2003) 0.84
Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease. Neurobiol Dis (2006) 0.84
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem (2004) 0.84
Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test. Eur J Pharmacol (2006) 0.84
Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. Neurol Sci (2008) 0.84
Evaluation of thermal water in patients with functional dyspepsia and irritable bowel syndrome accompanying constipation. World J Gastroenterol (2006) 0.83
Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause (2006) 0.83
Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity. J Headache Pain (2010) 0.83
The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study. Parkinsonism Relat Disord (2009) 0.83
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. Mov Disord (2010) 0.82
Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson's disease. Ann N Y Acad Sci (2003) 0.82
An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans. J Pain (2013) 0.82
Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. Headache (2012) 0.82
Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception (2013) 0.82
Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations. Neurogenetics (2011) 0.82
Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol (2011) 0.82
Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the 'CARE' protocol). Cephalalgia (2013) 0.82
Neurophysiological approach to central pain modulation in primary headaches. J Headache Pain (2005) 0.82
Lack of trigemino-cervical reflexes in progressive supranuclear palsy. Mov Disord (2008) 0.81
Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease. Brain Res (2007) 0.81